Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/23158Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kyritsis, A. P. | en |
| dc.date.accessioned | 2015-11-24T19:30:44Z | - |
| dc.date.available | 2015-11-24T19:30:44Z | - |
| dc.identifier.issn | 0167-594X | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/23158 | - |
| dc.rights | Default Licence | - |
| dc.subject | Antineoplastic Combined Chemotherapy Protocols/*therapeutic use | en |
| dc.subject | Double-Blind Method | en |
| dc.subject | Humans | en |
| dc.subject | Interferon-alpha/therapeutic use | en |
| dc.subject | Meningeal Neoplasms/*drug therapy/pathology | en |
| dc.subject | Meningioma/*drug therapy/pathology | en |
| dc.subject | Mifepristone/therapeutic use | en |
| dc.subject | Retreatment | en |
| dc.title | Chemotherapy for meningiomas | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/8858533 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1996 | - |
| heal.abstract | The most efficacious treatment for meningiomas is surgery. For incompletely resected or recurrent tumors, radiotherapy can be given. However, when the meningioma is unresectable and/or all other previous treatments have failed, immunotherapy or chemotherapy may be considered for malignant tumors and immunotherapy and hormone therapy may be considered for benign ones. Various chemotherapy treatments that have shown some efficacy in individual cases include combinations of Adriamycin and Dacarbazine or Ifosfamide and Mesna. The most effective immunotherapy appears to be administration of interferon-alpha, which is relatively non-toxic and easily tolerated. However, more studies are needed to better define the roles of these agents in the management of a recurrent, unresectable, or malignant meningiomas. | en |
| heal.journalName | J Neurooncol | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
